Evidence map›Paper›PMID 29333051›Full record

ArticlePharmacognosy research2017

Therapeutic Significance of

Sri Kumaran Nadarajah, Radha Vijayaraj, Jayaprakashvel Mani

Open access · hybridAbstract read
In one paragraph

Article in Pharmacognosy research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Insights into Common Octopus (Marine drugs · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sri Kumaran NadarajahDepartment of Marine Biotechnology, AMET University, Chennai, Tamil Nadu, India.
Radha VijayarajDepartment of Marine Biotechnology, AMET University, Chennai, Tamil Nadu, India.
Jayaprakashvel ManiDepartment of Marine Biotechnology, AMET University, Chennai, Tamil Nadu, India.
AMET University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe squid ink extract is well known for its biomedical properties.

objectiveIn this study, squid MATERIALS AND

methodsProximate composition of the crude squid ink was studied and found to have protein as the major component over lipid and carbohydrates. Further, bioactive fractions of squid ink were extracted with ethanol, and therapeutic applications such as hemolytic, antioxidant, antimicrobial, and

resultsIn hemolytic assay, the squid ink extract exhibited a maximum hemolytic activity of 128 hemolytic unit against tested erythrocytes. In DPPH assay, the ethanolic extract of squid ink has exhibited an antioxidant activity of 83.5%. The squid ink was found to be potent antibacterial agent against the pathogens tested. 200 μL of

conclusionHence, results of this study concluded that the ethanolic extract of SUMMARY: Squid ink is very high in a number of important nutrients. It's particularly high in antioxidants for instance, which as well all know help to protect the cells and the heart against damage from free radicals. In the present study, the squid ink have antioxidant, anti-inflammatory and cytotoxic properties and can be considered as promising the developing the drugs.

Indexed as

Anti-inflammatoryantimicrobialDPPHhemolytic activityink extractsLoligo vulgaris

Identifiers

PMID29333051
PMCPMC5757319
OpenAlexW2771994896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.